title: Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma.
authors: F
authors: F
authors: Biondo
authors: A
authors: A
authors: Matturro
authors: C
authors: C
authors: Santoro
authors: A
authors: A
authors: Leporace
authors: G
authors: G
authors: D'Elia
authors: E
authors: E
authors: Baldacci
authors: P
authors: P
authors: Pignoloni
authors: A
authors: A
authors: Pulsoni
authors: R
authors: R
authors: Foà
authors: M
authors: M
authors: Mazzucconi
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D060828:Induction Chemotherapy / Q000379:methods; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy*; D014842:von Willebrand Diseases / Q000188:drug therapy* / Q000209:etiology; D014841:von Willebrand Factor
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D014841:von Willebrand Factor; D000069283:Rituximab